Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Retatrutide (LY3437943, also referred to informally as "reta peptide") is a synthetic 39-amino-acid peptide developed by Eli Lilly that acts simultaneously on three distinct metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor
For dry capsules or tablets, brands should ask whether the CoQ10 is standard crystalline powder, micronized CoQ10, beadlet, emulsified powder, or another enhanced-dispersion form
SIRT4 enhances the sensitivity of ER-positive breast cancer to tamoxifen by inhibiting the IL-6/STAT3 signal pathway
Can peptides improve skin health
One recurring theme is the role of oxidative stress in aging and how melatonin and nutritional antioxidants may slow aging processes
Effects of Liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial
US$ 26.48
US$ 22.77
US$ 27.62
US$ 27.22
US$ 25.70
US$ 29.52
US$ 28.95
US$ 26.33
US$ 25.54
US$ 21.46
US$ 21.59
